negative Enterobacteriaceae with resistance to carbapenems conferred by New Delhi metallo-b-lactamase (NDM-1) are increasingly recognized as a global public health issue. 1e8 The World Health Organization (WHO) has chosen antimicrobial resistance as its theme for World Health Dayd7 April 2011. 9 The organization strongly recommends that governments focus control and prevention efforts in four main areas including surveillance of antimicrobial resistance; rational antibiotic use, which includes educating health care workers and the public about the appropriate use of antibiotics; introducing or enforcing legislation related to stopping the selling of antibiotics without prescription; and strict adherence to infection prevention and control measures, including the use of hand-washing measures, particularly in health care facilities to limit the spread of multi-drug resistant strains and reduce the generation of antibioticresistant bacteria. 16 demonstrated that approximately 400,000 patients from 28 European countries suffered from infections because of strains of antibiotic-resistant bacteria, with Escherichia coli and Klebsiella pneumoniae being the most common causative pathogens. 17, 18 The proportion of third-generation cephalosporin-resistant E coli increased significantly from 1.7% in 2002 to 8% in 2009, whereas the proportion of E coli isolates with resistance to four classes of antimicrobials increased more than 5-fold from 0.6% in 2002 to 3.4% in 2009. 16 The increase in antibiotic resistance among K pneumoniae is even more dire. The European Centre for Disease Prevention and Control reported that the rate of resistance of K pneumoniae to powerful and last-line antibiotics, namely carbapenems, increased from less than 1% to more than 25% in the European Union, 2009. 17 The prevalence of MDROs in hospitals and medical centers in the USA has also increased steadily during the previous decade.
19e23 For 24 Furthermore, the prevalence of vancomycin-resistant enterococci (VRE) isolates has also increased markedly. 19, 25 For example, VRE isolates accounted for 25% and 28.5% of all nosocomial infections in intensive care units (ICUs) in 1999 and 2003 respectively. 19, 26, 27 Antimicrobial resistance is also a threat and challenge to the treatment of infectious diseases in Taiwan. 28,29 The Taiwan Nosocomial Infection Surveillance system, 2009, a nationwide surveillance study on the incidence and prevalence of antimicrobial resistance in Taiwan (Fig. 1B) ; and the proportion of E coli isolates resistant to carbapenems (imipenem or menorpenem or ertapenem) in ICUs in medical centers and regional hospitals increased (p Z 0.231) from 0.5% in 2003 to 2.6% in 2009 ( Fig. 2A) . The study also showed that the proportion of K pneumoniae isolates resistant to carbapenems in ICUs in medical centers and regional hospitals increased significantly (p Z 0.001) from 1.2% in 2003 to 6.0% in 2009 (Fig. 2B) ; that the proportion of Enterobacteriaceae isolates resistant to carbapenems (CRE) increased significantly (p Z 0.017) from 1.4% in 2003 to 4.5% in 2009 (Fig. 2C) ; and that the proportion of A baumannii isolates resistant to imipenem or menorpenem in ICUs in medical centers and regional hospitals increased significantly (p < 0.001) from 18.0% in 2003 to 63.5% in 2009 (Fig. 2D) . Furthermore, the study also found that the proportion of Pseudomonas aeruginosa isolates resistant to imipenem or menorpenem in ICUs in medical centers and regional hospitals remained stable (15%) during the study period.
Risk factors for antibiotics resistance
Several factors may lead to the increase in antimicrobial resistance, such as hospital stay before ICU admission, hospitalization period before ICU admission, length of ICU stay, surgical ICU stay, the type of operation, previous antibiotic use, inappropriate use of antimicrobial drugs, 19 ,30À35 and inadequate adherence to infection control practices. In particular, some patients are more vulnerable to colonization and infections including those with severe disease, those with compromised host defenses because of underlying medical conditions, patients with recent surgery, and those with indwelling medical devices. Furthermore, hospitalized patients are likely to have more risk factors and higher infection rates than non-hospitalized patients, especially those who require treatment in the ICU. 32,49e52 Akinci et al. 53 demonstrated that patients with infections because of imipenem-resistant (IR) gram-negative bacteria have longer lengths of stay in ICUs compared with patients infected with imipenem-susceptible isolates. Furthermore, they found that the risk of IR gram-negative bacteria infection was four times higher for patients who undergo surgery and 3-fold higher for patients on carbapenem therapy. According to Kim et al. in Korea, the presence of neutropenia and the prolonged use of cephalosporin (more than 7 days) were more common among patients with bacteremia caused by IR isolates than among patients with bacteremia caused by imipenem-susceptible isolates (odds ratio 3.03 and 3.82, respectively). 54 They also confirmed that neutropenia and prolonged cephalosporin use (more than 7 days) were independent risk factors for metallo-b-lactamase-producing Acinetobacter bacteremia (odds ratio 22.10 and 19.57, respectively).
Impact of antibiotic resistance
Antimicrobial-resistant pathogens that cause health careassociated infections (HAIs) are becoming increasingly common. Studies have shown an association between the development of multi-drug resistance and increases in mortality, lengths of hospital stay, and cost of health care. 19 ,55e60 Comparisons of mortality rate, length of stay in hospitals, and health care costs between patients with methicillin-susceptible S aureus (MSSA) bacteremia and those with MRSA bacteremia have shown that patients with MRSA bacteremia have a significantly higher rate of mortality, markedly longer lengths of hospital stay, and higher median hospital costs than patients with MSSA bacteremia.
61e63 Furthermore, surgical site infections caused by MRSA were shown to be associated with a 3.4-fold higher risk for death and a 2-fold increase in median hospital costs than surgical site infections caused by MSSA infections. According to Blot et al. in Belgium, 64 patients with MRSA bacteremia had a higher 30-day mortality rate than patients with MSSA bacteremia (53.2% vs. 18.4%, p < 0.05) and a higher in-hospital mortality rate (63.8% vs. 23.7%, p < 0.05).
Taiwan CDC strategies for confronting antimicrobial resistance
Prevention of antimicrobial resistance depends on appropriate clinical practices that should be incorporated into all routine patient care. The Taiwan Centers for Disease Control (Taiwan CDC) takes a multifaceted, evidence-based approach in accordance with WHO's strategies in four main areas. 41 1. Surveillance of antimicrobial resistance 41 
Establishment of the Taiwan nosocomial infection
and antimicrobial resistance surveillance system ( Fig. 3 ): This system focuses on the monitoring of HAI and antimicrobial resistance.
To establish a national Communicable Disease
Reporting System for laboratories in Taiwan 67 3.1 Local health authorities will supervise pharmacies that sell antibiotics with a prescription. 3.2 Drug investigations and pharmaceutical-related regulations will be included to enrich and strengthen the knowledge and investigative ability of health officers when conducting national pharmaceutical seminars. 3.3 Notify all pharmacies to maintain self-discipline and not to sell antibiotic agents to the public without prescription. 3.4 Continue to promote medicine-pharmacy separation, and strengthen professional service of community pharmacies such as providing the public with correct medication advice. 3.5 Production, marketing and stocks will be listed as check points when follow and investigate domestic antibiotic factories. 3.6 To counsel and strengthen medical related industries and increase the knowledge of drug use among the public. 4. Strict adherence to infection prevention and control measures, including the use of hand hygiene measures, particularly in health care facilities 41, 65, 66 Reinforce infection control capacity in hospital/ medical institutions: continue to make improvements in hand hygiene measures, environmental cleaning, contact protection, standard operating procedures related to the handling of invasive equipment and other infection control measures. 4.1 Continue to promote the WHO "hand hygiene" campaign. Enforce hand hygiene by promoting hand hygiene as an integral part of patient safety, and by evaluating performance indicators regularly to encourage hospitals to improve continually. The three strategies of implementation include intervention, financial incentives, and performance. Promotion of hand hygiene among health care workers will comprise dividing hospitals into different groups according to the hospital level; rewarding participating hospitals for installing hand hygiene facilities; and encouraging hospitals to undertake system changes in hand hygiene measures and establishing demonstration centers for hand hygiene. Our goals are: (1) to promote the use of alcohol-based handrubs, increase the accessibility of hand hygiene facilities, and establish hand hygiene facilities at each point of care; (2) to raise health care workers' recognition in five moments for hand hygiene approach. This approach recommends health care workers to clean their hands before touching a patient, before clean/aseptic procedures, after body fluid exposure/risk, after touching a patient, and after touching patient surroundings; and (3) to diminish the rate of HAI and reduce costs for health care resources. 4.2 To conduct a project entitled "the integrated bundle to lower catheter-related bloodstream infections". 4.3 To establish infection control guidelines for monitoring, allocating, and isolating multi-drug resistant strains as well as caring for patients with infections because of MDROs by reviewing relevant studies in the medical literature, and by consulting the advisory committee and infectious disease control experts. The Department of Health needs to consider various views from medical practice units and institutions. After reviewing various points, infection control guidelines will be announced in each health care setting for reference and modification of standard procedures. 4.4 To establish a national infection control network (Fig. 4) . The Taiwan CDC divides Taiwan into six regions. Every region has a command center to help prevent and control infectious diseases in each region. The Taiwan CDC has also established a robust infection control framework in health care settings: this includes the supervision of establishing a hospital infection control committee and the assignment of physicians and nurses responsible for implementing and promoting infection control.
NDM-1 Enterobacteriaceae in Taiwan
According to the Communicable Disease Control Act and to require medical institutes and personnel to report such cases and offer a basis for implementing control measures for public health issues, the Taiwan CDC decided to include NDM-1 Enterobacteriaceae infection as a Category IV Notifiable Infectious Disease on September 9, 2010.
68
Although no confirmed cases of NDM-1 Enterobacteriaceae infection had been identified in Taiwan at that time, clinicians were, nonetheless, required to report NDM-1 Enterobacteriaceae infection within 24 hours of diagnosis to the Taiwan CDC Notifiable Infectious Disease Reporting System (Fig. 5) clinical, epidemiological and laboratory characteristics. 5. Clinicians must file a report on the cases that meet the aforementioned characteristics within 24 hours of diagnosis. Specimens from the patients must also be collected and submitted to the Taiwan CDC for final identification. Clinicians are also welcome to report cases that meet only the clinical and epidemiological characteristics but that could not be verified for drug resistance to the health authorities.
The Taiwan CDC confirmed the first case of NDM-1 Enterobacteriaceae infection in Taiwan on January 14, 2011. 69 The isolate was confirmed to be NDM-1 Klebsiella oxytoca. In accordance with the Communicable Disease Control Act, the hospital reported the case to the health authority on January 10, 2011. The hospital has been implementing all relevant infection control measures according to standard operating procedures of the Taiwan CDC for reporting NDM-1 Enterobacteriaceae infection (Fig. 6) . The abovementioned case has been receiving medical treatment in a single room since his admission to the hospital. During the period October to December, 2010, this was the only case among 81 isolates of CRE that tested positive for NDM-1 in the hospital. So far, there is no evidence of nosocomial infection involving NDM-1 Enterobacteriaceae in that hospital. In Taiwan, the CDC, major medical centers, and research institutes have collected a total of 1,000 CRE strains and none of them were NDM-1-positive Enterobacteriaceae. Consequently, the case is suspected to be an imported case but more information will be collected and studied to confirm that hypothesis.
To combat antimicrobial resistance and its global spread, the Taiwan CDC continuously works on control measures based on WHO's recommendations such as coordinating the implementation of hospital accreditation associated infection control inspection programs, boosting the quality of the infection control inspection programs, and giving advice or sharing experience on infection control practices through on-site audits to improve the performance of infection control programs in health care settings. The CDC has also established the Taiwan Nosocomial Infection and Antimicrobial Resistance Surveillance system for gathering and documenting surveillance data on the occurrence of HAIs and the status of antimicrobial resistance nationwide. To date, the system is used by 100% of medical centers and over 90% of the regional hospitals in Taiwan.
In addition to the four-point framework for planning and implementing relative approaches, the Taiwan CDC will also promote the implementation of hospital infection control measures at a reasonable operating cost. Together with the medical payment system, these measures will leverage hospitals' motives. Effective infection control can prevent at least 20% of HAIs. Hence, medical resources can be saved if the occurrence of HAIs is prevented. However, some determinants may influence the effectiveness of infection control measures such as allocation and training of clinical human resources; the availability of equipment, supplies, and hospital hardware; ward allocation of infected patients; management support, and investment. The above determinants are related to funding allocation. To reduce the problem caused by antimicrobial resistance, the medical payment system needs to be combined. This includes the rationalization and enhancement of the national health insurance system. The performance and assessment of health care settings' infection control will be based on peer ratings. As a result, this might provide appropriate care to those affected by microbes and protect patients' rights. Multi-drug resistant bacteria are not new and will continue to appear. Therefore, the Taiwan CDC will make every effort to combat antimicrobial resistance by targeting consumers, prescribers and dispensers, veterinarians, managers of hospitals and diagnostic laboratories, patients and visitors to health care facilities, as well as national governments, the pharmaceutical industry, professional societies, and international agencies.
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